Logo

SeeTreat receives CUREator+ grant

We are proud to be part of eight Australian startups developing innovations with the potential to save lives and improve wellbeing receiving grants totalling $18.5 million thanks to the first CUREator+ funding round 🎉

Delivered in partnership with Brandon BioCatalyst (Brandon Capital) and ANDHealth, CUREator+ is a national program focused on accelerating the research translation and commercialisation of preclinical and clinical early-stage Australian medical research and medical innovations with commercial potential.

These innovations include drugs (novel and repurposed), devices, diagnostics and digital technologies that address unmet needs.

The first-round recipients are:

  1. ⭐️ Amplificare: Enabling rapid assessment of the efficacy of cancer treatments
  2. ⭐️ Baymatob: AI-powered platform providing early warning for treatable pregnancy and labour complications
  3. ⭐️ Currus Biologics Pty Ltd: Technology to develop CAR T-cell Therapy in tumours
  4. ⭐️ Kinoxis Therapeutics Pty Ltd: An alternative to antipsychotics for managing agitation and aggression in dementia
  5. ⭐️ Micromune Therapeutics: A therapy for treating inflammatory bowel disease
  6. ⭐️ Mirugen: Utilising gene therapy to restore vision in patients with 'incurable' blindness
  7. ⭐️ OncoRes Medical: Imaging technology which differentiates cancer from healthy tissue
  8. ⭐️ SeeTreat Medical: Software to improve the accuracy and effectiveness of radiation therapy for breast cancer

The Hon Mark Butler MP, Minister for Health and Aged Care, said, “Turning new research into medicines and tools which can be used to treat patients is often a long and costly process. Our support will ensure innovative research can become life changing and lifesaving treatments.”

ANDHealth CEO Bronwyn Le Grice said, “In the current market, substantive equity-free funding such as provided under CUREator+ and access to global industry leaders with proven track records, can make a material difference to the speed and success of commercialising these exciting new technologies.”

👉 Learn more: https://loom.ly/pUOUliw

CUREator+ is supported by funding from the Medical Research Future Fund (MRFF) BioMedTech Incubator (BMTI) program.